547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
Vertex Pharmaceuticals's market cap is 138.65B USD: 253,461,000 shares outstanding at today's price of 547.03.
- Today
- 138.65B
- Average, 5 years
- 114.00B
- Low, 5 years
- 46.83B
- High, 5 years
- 142.02B
Market cap = price × shares outstanding = 547.03 × 253.46M = 138.65B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 138.65B | |
| FY2025 | 31 Dec 2025 | 115.92B |
| FY2024 | 31 Dec 2024 | 103.70B |
| FY2023 | 31 Dec 2023 | 104.86B |
| FY2022 | 31 Dec 2022 | 73.96B |
| FY2021 | 31 Dec 2021 | 56.59B |
| FY2020 | 31 Dec 2020 | 61.41B |
| FY2019 | 31 Dec 2019 | 56.21B |
| FY2018 | 31 Dec 2018 | 42.14B |
| FY2017 | 31 Dec 2017 | 37.29B |
| FY2016 | 31 Dec 2016 | 17.95B |
| FY2015 | 31 Dec 2015 | 30.30B |
| FY2014 | 31 Dec 2014 | 27.91B |
| FY2013 | 31 Dec 2013 | 16.70B |
| FY2012 | 31 Dec 2012 | 8.88B |
| FY2011 | 31 Dec 2011 | 6.80B |
| FY2010 | 31 Dec 2010 | 7.02B |
| FY2009 | 31 Dec 2009 | 7.42B |
| FY2008 | 31 Dec 2008 | 4.27B |
| FY2007 | 31 Dec 2007 | 3.00B |
| FY2006 | 31 Dec 2006 | 4.24B |
| FY2005 | 31 Dec 2005 | 2.47B |
| FY2004 | 31 Dec 2004 | 830.50M |
| FY2003 | 31 Dec 2003 | 796.99M |
| FY2002 | 31 Dec 2002 | 1.20B |
| FY2001 | 31 Dec 2001 | 1.83B |
| FY2000 | 31 Dec 2000 | 4.84B |
| FY1999 | 31 Dec 1999 | 893.13M |
| FY1998 | 31 Dec 1998 | 752.65M |
| FY1997 | 31 Dec 1997 | 800.71M |
| FY1996 | 31 Dec 1996 | 752.34M |
| FY1995 | 31 Dec 1995 | 452.18M |
| FY1994 | 31 Dec 1994 | 235.71M |
| FY1993 | 31 Dec 1993 | 231.25M |
| FY1992 | 31 Dec 1992 | 118.39M |
| FY1991 | 31 Dec 1991 | 107.79M |
| FY1990 | 31 Dec 1990 | 88.54M |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 132.53B |
| Q2 FY2026 | 30 Jun 2026 | 126.12B |
| Q1 FY2026 | 31 Mar 2026 | 113.47B |
| Q4 FY2025 | 31 Dec 2025 | 115.11B |
| Q3 FY2025 | 30 Sept 2025 | 100.10B |
| Q2 FY2025 | 30 Jun 2025 | 114.28B |
| Q1 FY2025 | 31 Mar 2025 | 124.55B |
| Q4 FY2024 | 31 Dec 2024 | 103.70B |
| Q3 FY2024 | 30 Sept 2024 | 119.99B |
| Q2 FY2024 | 30 Jun 2024 | 121.63B |
| Q1 FY2024 | 31 Mar 2024 | 108.57B |
| Q4 FY2023 | 31 Dec 2023 | 104.86B |
| Q3 FY2023 | 30 Sept 2023 | 89.72B |
| Q2 FY2023 | 30 Jun 2023 | 90.69B |
| Q1 FY2023 | 31 Mar 2023 | 81.10B |
| Q4 FY2022 | 31 Dec 2022 | 74.19B |
| Q3 FY2022 | 30 Sept 2022 | 74.27B |
| Q2 FY2022 | 30 Jun 2022 | 72.11B |
| Q1 FY2022 | 31 Mar 2022 | 66.57B |
| Q4 FY2021 | 31 Dec 2021 | 55.91B |
| Q3 FY2021 | 30 Sept 2021 | 46.78B |
| Q2 FY2021 | 30 Jun 2021 | 52.22B |
| Q1 FY2021 | 31 Mar 2021 | 55.74B |
| Q4 FY2020 | 31 Dec 2020 | 61.46B |
| Q3 FY2020 | 30 Sept 2020 | 70.86B |
| Q2 FY2020 | 30 Jun 2020 | 75.38B |
| Q1 FY2020 | 31 Mar 2020 | 61.82B |
| Q4 FY2019 | 31 Dec 2019 | 56.49B |
| Q3 FY2019 | 30 Sept 2019 | 43.53B |
| Q2 FY2019 | 30 Jun 2019 | 46.58B |
| Q1 FY2019 | 31 Mar 2019 | 47.57B |
| Q4 FY2018 | 31 Dec 2018 | 42.23B |
| Q3 FY2018 | 30 Sept 2018 | 48.83B |
| Q2 FY2018 | 30 Jun 2018 | 43.19B |
| Q1 FY2018 | 31 Mar 2018 | 41.27B |
| Q4 FY2017 | 31 Dec 2017 | 37.70B |
| Q3 FY2017 | 30 Sept 2017 | 38.05B |
| Q2 FY2017 | 30 Jun 2017 | 31.90B |
| Q1 FY2017 | 31 Mar 2017 | 26.90B |
| Q4 FY2016 | 31 Dec 2016 | 18.08B |
| Q3 FY2016 | 30 Sept 2016 | 21.17B |
| Q2 FY2016 | 30 Jun 2016 | 21.03B |
| Q1 FY2016 | 31 Mar 2016 | 19.38B |
| Q4 FY2015 | 31 Dec 2015 | 30.13B |
| Q3 FY2015 | 30 Sept 2015 | 25.20B |
| Q2 FY2015 | 30 Jun 2015 | 29.73B |
| Q1 FY2015 | 31 Mar 2015 | 28.23B |
| Q4 FY2014 | 31 Dec 2014 | 28.26B |
| Q3 FY2014 | 30 Sept 2014 | 26.52B |
| Q2 FY2014 | 30 Jun 2014 | 22.14B |
| Q1 FY2014 | 31 Mar 2014 | 16.41B |
| Q4 FY2013 | 31 Dec 2013 | 17.18B |
| Q3 FY2013 | 30 Sept 2013 | 17.37B |
| Q2 FY2013 | 30 Jun 2013 | 17.68B |
| Q1 FY2013 | 31 Mar 2013 | 11.63B |
| Q4 FY2012 | 31 Dec 2012 | 8.99B |
| Q3 FY2012 | 30 Sept 2012 | 12.03B |
| Q2 FY2012 | 30 Jun 2012 | 11.82B |
| Q1 FY2012 | 31 Mar 2012 | 8.53B |
| Q4 FY2011 | 31 Dec 2011 | 6.91B |
| Q3 FY2011 | 30 Sept 2011 | 9.16B |
| Q2 FY2011 | 30 Jun 2011 | 10.63B |
| Q1 FY2011 | 31 Mar 2011 | 9.70B |
| Q4 FY2010 | 31 Dec 2010 | 7.05B |
| Q3 FY2010 | 30 Sept 2010 | 6.94B |
| Q2 FY2010 | 30 Jun 2010 | 6.59B |
| Q1 FY2010 | 31 Mar 2010 | 8.13B |
| Q4 FY2009 | 31 Dec 2009 | 8.52B |
| Q3 FY2009 | 30 Sept 2009 | 6.77B |
| Q2 FY2009 | 30 Jun 2009 | 6.21B |
| Q1 FY2009 | 31 Mar 2009 | 4.48B |
| Q4 FY2008 | 31 Dec 2008 | 4.52B |
| Q3 FY2008 | 30 Sept 2008 | 4.66B |
| Q2 FY2008 | 30 Jun 2008 | 4.64B |
| Q1 FY2008 | 31 Mar 2008 | 3.21B |
| Q4 FY2007 | 31 Dec 2007 | 3.04B |
| Q3 FY2007 | 30 Sept 2007 | 5.07B |
| Q2 FY2007 | 30 Jun 2007 | 3.69B |
| Q1 FY2007 | 31 Mar 2007 | 3.53B |
| Q4 FY2006 | 31 Dec 2006 | 4.64B |
| Q3 FY2006 | 30 Sept 2006 | 3.80B |
| Q2 FY2006 | 30 Jun 2006 | 3.98B |
| Q1 FY2006 | 31 Mar 2006 | 3.93B |
| Q4 FY2005 | 31 Dec 2005 | 2.97B |
| Q3 FY2005 | 30 Sept 2005 | 2.11B |
| Q2 FY2005 | 30 Jun 2005 | 1.39B |
| Q1 FY2005 | 31 Mar 2005 | 743.45M |
| Q4 FY2004 | 31 Dec 2004 | 835.82M |
| Q3 FY2004 | 30 Sept 2004 | 826.79M |
| Q2 FY2004 | 30 Jun 2004 | 854.27M |
| Q1 FY2004 | 31 Mar 2004 | 735.65M |
| Q4 FY2003 | 31 Dec 2003 | 804.88M |
| Q3 FY2003 | 30 Sept 2003 | 947.92M |
| Q2 FY2003 | 30 Jun 2003 | 1.12B |
| Q1 FY2003 | 31 Mar 2003 | 851.22M |
| Q4 FY2002 | 31 Dec 2002 | 1.21B |
| Q3 FY2002 | 30 Sept 2002 | 1.40B |
| Q2 FY2002 | 30 Jun 2002 | 1.16B |
| Q1 FY2002 | 31 Mar 2002 | 2.13B |
| Q4 FY2001 | 31 Dec 2001 | 1.84B |
| Q3 FY2001 | 30 Sept 2001 | 1.27B |
| Q2 FY2001 | 30 Jun 2001 | 2.99B |
| Q1 FY2001 | 31 Mar 2001 | 2.20B |
| Q4 FY2000 | 31 Dec 2000 | 4.26B |
| Q3 FY2000 | 30 Sept 2000 | 4.55B |
| Q2 FY2000 | 30 Jun 2000 | 2.77B |
| Q1 FY2000 | 31 Mar 2000 | 1.22B |
| Q4 FY1999 | 31 Dec 1999 | 903.77M |
| Q3 FY1999 | 30 Sept 1999 | 793.20M |
| Q2 FY1999 | 30 Jun 1999 | 614.71M |
| Q1 FY1999 | 31 Mar 1999 | 634.86M |
| Q4 FY1998 | 31 Dec 1998 | 748.00M |
| Q3 FY1998 | 30 Sept 1998 | 529.00M |
| Q2 FY1998 | 30 Jun 1998 | 551.25M |
| Q1 FY1998 | 31 Mar 1998 | 789.04M |
| Q4 FY1997 | 31 Dec 1997 | 815.29M |
| Q3 FY1997 | 30 Sept 1997 | 928.02M |
| Q2 FY1997 | 30 Jun 1997 | 892.50M |
| Q1 FY1997 | 31 Mar 1997 | 903.46M |
| Q4 FY1996 | 31 Dec 1996 | 897.88M |
| Q3 FY1996 | 30 Sept 1996 | 546.62M |
| Q2 FY1996 | 30 Jun 1996 | 574.92M |
| Q1 FY1996 | 31 Mar 1996 | 443.18M |
| Q4 FY1995 | 31 Dec 1995 | 437.36M |
| Q3 FY1995 | 30 Sept 1995 | 323.44M |
| Q2 FY1995 | 30 Jun 1995 | 283.41M |
| Q1 FY1995 | 31 Mar 1995 | 226.61M |
| Q4 FY1994 | 31 Dec 1994 | 245.91M |
| Q3 FY1994 | 30 Sept 1994 | 231.56M |
| Q2 FY1994 | 30 Jun 1994 | 187.15M |
| Q1 FY1994 | 31 Mar 1994 | 194.55M |
| Q4 FY1993 | 31 Dec 1993 | 260.98M |
| Q3 FY1993 | 30 Sept 1993 | 156.48M |
| Q2 FY1993 | 30 Jun 1993 | 126.67M |
| Q1 FY1993 | 31 Mar 1993 | 94.29M |
| Q4 FY1992 | 31 Dec 1992 | 114.91M |
| Q3 FY1992 | 30 Sept 1992 | 129.86M |
| Q2 FY1992 | 30 Jun 1992 | 89.06M |
| Q1 FY1992 | 31 Mar 1992 | 134.29M |
| Q4 FY1991 | 31 Dec 1991 | 168.57M |
| Q3 FY1991 | 30 Sept 1991 | 126.43M |
| Q2 FY1991 | 30 Jun 1991 | 88.54M |
| Q1 FY1991 | 31 Mar 1991 | 88.54M |
| Q4 FY1990 | 31 Dec 1990 | 88.54M |
| Q3 FY1990 | 30 Sept 1990 | 88.54M |
| Q2 FY1990 | 30 Jun 1990 | 88.54M |
| Q1 FY1990 | 31 Mar 1990 | 88.54M |
See also:P/E ratio,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Vertex Pharmaceuticals's market cap
Source: Financial Modeling Prep
